Hologic Inc at BTIG Virtual MedTech, Digital Health, Life Sciences, and Diagnostic Tools Conference Transcript
All right. Good morning, and welcome again to the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference. I'm Ryan Zimmerman, Senior MedTech Analyst here at BTIG.
We're excited to have Hologic here with us today, coming off of a wonderful article, I might add, this weekend from Barron's. If you haven't had a chance to read that, you definitely should.
With us from Hologic is Karleen Oberton, Chief Financial Officer; and Michael Watts, Vice President of Investor Relations. Thank you both for joining us.
Questions & Answers
Maybe, Karleen, let's just jump right into questions. I think most investors know Hologic. We can skip the intro spiel.
But if I think back before COVID, Hologic was a low single-digit to mid-single-digit growth company. And in the process of moving to mid-single digits more consistently, I think
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
